The Director of the HRB Clinical Research Facility at NUI Galway, Professor Francis Giles has been awarded the Annual Saint Luke's Silver Award by the Royal Academy of Medicine in Ireland. This is the highest honour bestowed by the Academy and Professor Giles is the first NUI Galway recipient. Professor Giles also delivered the 36th Saint Luke's Lecture entitled Optimising Ireland's Contribution to Curing Cancer, in Dublin this week. The Saint Luke's Lecture is sponsored by the Academy and Saint Luke's Hospital. This lecture is in the field of oncology. The lecturer is selected by an Academy/Saint Luke's committee and receives the silver medal and an honorarium. The Annual Saint Luke s Lecture has attracted a distinguished list of speakers over the years and its prestige is recognised by the award of the highest medal from the Royal Academy of Medicine in Ireland. Recipients must also submit a paper to the Irish Journal of Medical Science. Congratulating Professor Giles, NUI Galway President, Dr James J. Browne, said: "This accolade is a wonderful tribute to Frank s work as a leading international researcher and clinician. It highlights the calibre of work underway at NUI Galway in the area of cancer research, as part of our strong translational focus in the area of biomedical engineering science." At the 36th Saint Luke's Lecture in Dublin, Professor Giles delivered his vision for stimulating Irish anti-cancer research. His lecture entitled Optimising Ireland's Contribution to Curing Cancer defined a path based on the US National Cancer Institute designated Cancer Center template. He highlighted recent relevant US activity including the creation of a National Center for Advancing Translational Sciences (NCATS) that will focus on early phase drug development. His key recommendations include increased emphasis on collaboration with other European early phase research sites through organisations like the Developmental Therapeutics Consortium. He summarised the high standard and broad scope of research being conducted by Irish investigators around the world. With the HRB Clinical Research Facilities in Cork, Dublin, and Galway as interdigitated hubs, he emphasised Ireland's strong position as a contributor to the global efforts to relieve the suffering associated with cancer and to cure those afflicted by it. Frank Giles is a Professor of Cancer Therapeutics at NUI Galway and Trinity College Dublin. He was appointed Director of the HRB Clinical Research Facility at NUI Galway in September 2010. He also was appointed Consultant Haematologist at St James's Hospital, Dublin and Galway University Hospital. Professor Giles continues to be a Professor of Medicine at the University of Texas Health Science Centre at San Antonio. An award-winning Professor, he has won the BioLink USA-Ireland Lifescience Award for 2007 and the NUI Galway Alumni Award for Health Care and Medical Science, 2007. Also at this year's Saint Luke's Lecture, NUI Galway graduate Dr Patricia McGowan was awarded the Saint Luke's Young Investigator Award. This is the eighth year of the award, which is sponsored on an annual basis by the Royal Academy of Medicine in Ireland and Saint Luke's Hospital. Applicants are normally in their early years of oncology research and would in normal circumstances be no more than five years post MD/PhD or equivalent level. Dr McGowan of the UCD School of Biomolecular and Biomedical Science was awarded the Academy Bronze medal. -Ends-